title: Backlash over ritonavir  price hike.
abstract: On December 3, 2003, Abbott Laboratories, the pharmaceutical company that makes lopinavir (Kaletra), announced that it was going to raise the price of its other anti-HIV drug, ritonavir (Norvir), from $2.14 to $10.72 per capsule in the U.S.--an increase of 400%. (These prices reflect the Average Wholesale Price, or AWP, a national average of list prices charged by wholesalers to pharmacies.)
authors.forename: Bob
authors.initials: B
authors.lastname: Huff
mesh_terms: D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D019438:Ritonavir / Q000008:administration & dosage / Q000191:economics*; D014481:United States
chemical_list: D017320:HIV Protease Inhibitors; D019438:Ritonavir